Neurocrine Biosciences NBIX
NASDAQ NBIX
$154.17 -1.37 (-0.88%)
At close: Aug 20, 2026 · 12:54 PM UTC

Neurocrine Biosciences (NBIX) Share-based Compensation Growth (5y) (2015 - 2026)

Neurocrine Biosciences (NBIX) Share-based Compensation Growth (5y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.98 Bn 43.02 Bn -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn -
10 Alkermes 8.14 Bn 7.48 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 17.84%
Mar 31, 2026 28.34%
Sep 30, 2025 -27.25%
Jun 30, 2025 33.97%
Mar 31, 2025 18.29%
Dec 31, 2024 25.53%
Sep 30, 2024 42.70%
Jun 30, 2024 -31.84%
Mar 31, 2024 23.01%
Dec 31, 2023 24.54%
Sep 30, 2023 -4.67%
Jun 30, 2023 42.03%
Mar 31, 2023 14.95%
Dec 31, 2022 -63.36%
Sep 30, 2022 66.26%
Jun 30, 2022 -41.84%
Mar 31, 2022 32.75%
Dec 31, 2021 34.92%
Sep 30, 2021 42.56%
Jun 30, 2021 44.19%